Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q1 2025 · 10-Q
Revenue$22.19K$22.19Kno prior Q1 2024 on file Net Income-$205.75K-$205.75KN/M vs Q1 2024 EPS Diluted-$0.01-$0.01— vs Q1 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Operating Cash Flow-$26,069N/M Margins · derivedGross margin92.8%
Operating margin-924.3%
Net margin-927.3%
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end